TransMedics Group, Inc. (TMDX)

Stock Price Forecast

The 10 analysts that cover TransMedics Group stock have a consensus rating of "Buy" and an average price target of $127.33, which forecasts a -0.97% decrease in the stock price over the next year. The lowest target is $75 and the highest is $178.

Price Target: $127.33 (-0.97%)

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$75	$127.33	$120	$178
Change	-41.67%	-0.97%	-6.67%	+38.44%

Analyst Ratings

The average analyst rating for TransMedics Group stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Jan '25	Feb '25	Mar '25	Apr '25	May '25	Jun '25
Strong Buy	3	3	3	3	3	3
Buy	4	4	4	4	4	4
Hold	4	4	3	3	3	3
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	11	11	10	10	10	10

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Suraj Kalia Oppenheimer	Oppenheimer	Buy Maintains $130 → $150	Buy	Maintains	$130 → $150	+16.66%	Jun 17, 2025
Mike Matson Needham	Needham	Hold Reiterates n/a	Hold	Reiterates	n/a	n/a	Jun 17, 2025
Matt O'Brien Piper Sandler	Piper Sandler	Buy Reiterates $125 → $145	Buy	Reiterates	$125 → $145	+12.77%	Jun 4, 2025
Mike Matson Needham	Needham	Hold Reiterates n/a	Hold	Reiterates	n/a	n/a	Jun 3, 2025
Suraj Kalia Oppenheimer	Oppenheimer	Buy Maintains $125 → $130	Buy	Maintains	$125 → $130	+1.10%	May 9, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

591.98M

Increased by 34.07%

from 441.54M

Revenue Next Year

714.86M

Increased by 20.76%

from 591.98M

EPS This Year

1.84

Increased by 82.44%

from 1.01

EPS Next Year

2.59

Increased by 40.77%

from 1.84

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	25.64M	30.26M	93.46M	241.62M	441.54M	591.98M	714.86M	842.03M
Revenue Growth	8.62%	18.03%	208.83%	158.53%	82.74%	34.07%	20.76%	17.79%
EPS	-1.16	-1.60	-1.23	-0.77	1.01	1.84	2.59	3.31
EPS Growth	-	-	-	-	-	82.44%	40.77%	27.63%
Forward PE	-	-	-	-	-	69.78	49.57	38.84
No. Analysts	-	-	-	-	-	12	12	9

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027	2028	2029
High	614.8M	769.3M	928.3M
Avg	592.0M	714.9M	842.0M
Low	564.7M	643.9M	750.7M

Revenue Growth

Revenue Growth	2025	2026	2027	2028	2029
High	39.2%	30.0%	29.9%
Avg	34.1%	20.8%	17.8%
Low	27.9%	8.8%	5.0%

EPS Forecast

EPS	2025	2026	2027
High	2.03	3.10	4.17
Avg	1.84	2.59	3.31
Low	1.69	2.08	2.41

EPS Growth

EPS Growth	2025	2026	2027
High	100.6%	68.1%	60.7%
Avg	82.4%	40.8%	27.6%
Low	66.9%	12.8%	-7.1%

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.